Small loans for small businesses
Business Ownership of Indiana is ramping up its micro-lending program, awarding a $10,000 loan to Indianapolis-based Stage Ninja LLC. Can such small amounts make a difference to fledgling firms?
Business Ownership of Indiana is ramping up its micro-lending program, awarding a $10,000 loan to Indianapolis-based Stage Ninja LLC. Can such small amounts make a difference to fledgling firms?
New health insurance coverage created by the 2010 health reform law will attract a lower-income, less-educated and more diverse set of customers than the insurance markets that exist today, according to a new analysis by PricewaterhouseCoopers. And that could create challenges for doctors and hospitals trying to care for those patients.
Eli Lilly and Co.’s Alzheimer’s drug slowed cognitive decline 34 percent in patients with mild forms of the disease, according to an analysis of Lilly’s clinical trial data released Monday. Lilly’s share price jumped more than 5 percent on the news.
People listings are free. Information must be submitted at least 11 days before the Monday issue in which it is to appear. Publication of information might be delayed due to space limitations. To submit information and photos online go to www.ibj.com and use the People submissions form. Photos may be sent as jpegs, 300 dpi […]
I’ll bet you’re not an undecided voter. How do I know? Because you’re reading this opinion piece in this political publication that resides within a larger publication that’s focused on a narrow set of issues. In other words, you’re engaged.
Let me tell you about Ralph. Ralph is among 78 percent of IndyGo riders who have no vehicle available, 65 percent who are employed, and 70 percent who earn less than $25,000 a year.
Thanks to blossoming relationships with corporate behemoths like Microsoft and JPMorgan Chase, local ad agency Bradley and Montgomery is making plans to double its 50-employee work force.
Indianapolis-based ExactTarget Inc., which grew up as an e-mail blasting company focused on consumers, is trying to entrench itself as a one-stop shop for smartly interacting with all manner of customers.
Eli Lilly and Co. has apparently made major medical history by being the first to develop a drug that alters the course of Alzheimer’s disease. But whether Lilly can be the first to make major money from a disease-altering Alzheimer’s drug is still in doubt.
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
Indianapolis-based medical-device maker Catheter Research Inc. will receive a new kind of sterilization machine in December that it hopes will reduce costs and wait times for medical-device companies in the Midwest—including itself.
A union president says no layoffs are planned among the research, technical and support employees at Indiana operations as engine maker Cummins Inc. makes cutbacks.
Oct. 18-27
Various locations
There’s lots to see—and sift through—at the annual cinematic celebration. But how to pick? Click here for some of my recommendations (My favorite: “Starry, Starry Night”). But don’t treat mine as an exhaustive list. The two dozen or so films I screened are only a small part of the overall festival. Talk to your fellow audience members. Do a little Internet searching. Or just take a chance on something you are otherwise unlikely to see at the multiplex—like a documentary about trash truck choreography. Details here.
The initial batch of 10,000 orange ChuckStrong bracelets are available at Colts Pro Shops at Circle Centre Mall and Lucas Oil Stadium and online. Team officials expect them to sell fast.
Most repetitive tasks can be done by computer nowadays, but many can’t.
Researchers are set to test drugs by Eli Lilly and other companies that may prevent Alzheimer’s disease after efforts to find a cure have been unsuccessful.
Roche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
Eli Lilly and Co. is continuing a string of positive yet incomplete clinical trial results, giving it a boost among investors.